Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in MDS or AML Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial

NCT01746147 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT01746147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01746147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in MDS or AML Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial
Lead sponsor
GWT-TUD GmbH
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
December 31, 2016
Enrollment
134 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

mds and aml prior to allogeneic sct